Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
---|---|---|---|---|---|
EP3135275B1 | 13 May, 2020 | Pharmaceutical Composition Capable Of The Incorporation Of Lenalidomide In Various Crystalline Modifications | Aug, 2035 | 3 |